Supernus Pharmaceuticals, Inc. (SUPN)
USD 35.46
(-2.1%)
USD 35.46
(-2.1%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 523.74 Million USD | -24.33% |
| 2022 | 580.01 Million USD | 14.92% |
| 2021 | 504.71 Million USD | 7.86% |
| 2020 | 467.93 Million USD | 24.42% |
| 2019 | 376.09 Million USD | -4.43% |
| 2018 | 393.54 Million USD | 37.11% |
| 2017 | 287.02 Million USD | 41.38% |
| 2016 | 203.01 Million USD | 49.27% |
| 2015 | 136 Million USD | 16.96% |
| 2014 | 116.28 Million USD | 965.39% |
| 2013 | 10.91 Million USD | 637.5% |
| 2012 | 1.48 Million USD | 84.31% |
| 2011 | 803 Thousand USD | -94.06% |
| 2010 | 13.51 Million USD | -70.95% |
| 2009 | 46.51 Million USD | 423.29% |
| 2008 | 8.88 Million USD | 109.96% |
| 2007 | 4.23 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 129.7 Million USD | 21.69% |
| 2024 Q3 | 138.01 Million USD | 6.41% |
| 2024 Q1 | 106.58 Million USD | -13.35% |
| 2023 Q2 | 114.47 Million USD | -12.15% |
| 2023 Q1 | 130.3 Million USD | -9.75% |
| 2023 FY | 438.88 Million USD | -24.33% |
| 2023 Q4 | 123.01 Million USD | -8.39% |
| 2023 Q3 | 134.27 Million USD | 17.3% |
| 2022 Q4 | 144.37 Million USD | -4.69% |
| 2022 FY | 580.01 Million USD | 14.92% |
| 2022 Q3 | 151.47 Million USD | 1.26% |
| 2022 Q1 | 134.57 Million USD | -5.27% |
| 2022 Q2 | 149.59 Million USD | 11.16% |
| 2021 Q2 | 116.3 Million USD | 0.28% |
| 2021 FY | 504.71 Million USD | 7.86% |
| 2021 Q4 | 142.05 Million USD | 8.96% |
| 2021 Q1 | 115.97 Million USD | -7.24% |
| 2021 Q3 | 130.37 Million USD | 12.1% |
| 2020 Q3 | 133.74 Million USD | 13.02% |
| 2020 FY | 467.93 Million USD | 24.42% |
| 2020 Q1 | 90.82 Million USD | -5.72% |
| 2020 Q2 | 118.34 Million USD | 30.3% |
| 2020 Q4 | 125.02 Million USD | -6.52% |
| 2019 Q2 | 100.65 Million USD | 23.06% |
| 2019 FY | 376.09 Million USD | -4.43% |
| 2019 Q1 | 81.79 Million USD | -26.81% |
| 2019 Q4 | 96.33 Million USD | -1.02% |
| 2019 Q3 | 97.32 Million USD | -3.31% |
| 2018 Q3 | 98.78 Million USD | 3.06% |
| 2018 Q2 | 95.85 Million USD | 9.99% |
| 2018 Q1 | 87.15 Million USD | 3.41% |
| 2018 Q4 | 111.74 Million USD | 13.12% |
| 2018 FY | 393.54 Million USD | 37.11% |
| 2017 Q4 | 84.28 Million USD | 10.68% |
| 2017 FY | 287.02 Million USD | 41.38% |
| 2017 Q3 | 76.14 Million USD | 5.81% |
| 2017 Q2 | 71.96 Million USD | 31.74% |
| 2017 Q1 | 54.62 Million USD | -6.78% |
| 2016 FY | 203.01 Million USD | 49.27% |
| 2016 Q2 | 47.67 Million USD | 16.15% |
| 2016 Q4 | 58.6 Million USD | 9.78% |
| 2016 Q3 | 53.38 Million USD | 11.98% |
| 2016 Q1 | 41.04 Million USD | 2.96% |
| 2015 Q4 | 39.86 Million USD | 9.7% |
| 2015 FY | 136 Million USD | 16.96% |
| 2015 Q3 | 36.33 Million USD | 9.16% |
| 2015 Q2 | 33.29 Million USD | 25.55% |
| 2015 Q1 | 26.51 Million USD | -7.03% |
| 2014 Q2 | 28.01 Million USD | 226.24% |
| 2014 Q1 | 8.58 Million USD | -7.35% |
| 2014 Q4 | 28.51 Million USD | -44.26% |
| 2014 FY | 116.28 Million USD | 965.39% |
| 2014 Q3 | 51.16 Million USD | 82.65% |
| 2013 FY | 10.91 Million USD | 637.5% |
| 2013 Q4 | 9.26 Million USD | 657.19% |
| 2013 Q3 | 1.22 Million USD | 341.88% |
| 2013 Q2 | 277 Thousand USD | 88.44% |
| 2013 Q1 | 147 Thousand USD | -86.51% |
| 2012 Q2 | 91 Thousand USD | -56.25% |
| 2012 Q1 | 208 Thousand USD | 102.11% |
| 2012 Q3 | 91 Thousand USD | 0.0% |
| 2012 Q4 | 1.09 Million USD | 1097.8% |
| 2012 FY | 1.48 Million USD | 84.31% |
| 2011 Q3 | 11 Thousand USD | -98.53% |
| 2011 Q4 | -9.84 Million USD | -89600.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 FY | 803 Thousand USD | -94.06% |
| 2011 Q2 | 750 Thousand USD | 0.0% |
| 2010 Q4 | 4.77 Million USD | 0.0% |
| 2010 FY | 13.51 Million USD | -70.95% |
| 2009 FY | 46.51 Million USD | 423.29% |
| 2009 Q4 | 3.44 Million USD | 0.0% |
| 2008 FY | 8.88 Million USD | 109.96% |
| 2007 FY | 4.23 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Theratechnologies Inc. | 62.12 Million USD | -742.991% |
| Harrow Health, Inc. | 90.55 Million USD | -478.382% |
| Dynavax Technologies Corporation | 182.11 Million USD | -187.585% |
| Biofrontera Inc. | 16.62 Million USD | -3049.949% |
| Cronos Group Inc. | 6.99 Million USD | -7391.772% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -10937.766% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | -18.719% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 172952.145% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -17048.406% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -1464.067% |
| Radius Health, Inc. | 307.71 Million USD | -70.206% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -5096.946% |
| DURECT Corporation | 6.83 Million USD | -7567.135% |
| ProPhase Labs, Inc. | 16.23 Million USD | -3125.211% |
| Safety Shot Inc | -74.45 Thousand USD | 703515.394% |
| Phibro Animal Health Corporation | 312.48 Million USD | -67.604% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -94443.216% |
| Alvotech | -69.42 Million USD | 854.432% |
| Assertio Holdings, Inc. | 125.04 Million USD | -318.829% |
| Rockwell Medical, Inc. | 8.7 Million USD | -5917.256% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -6180.504% |
| Procaps Group S.A. | 239.56 Million USD | -118.618% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | -21.624% |
| SCYNEXIS, Inc. | 124.51 Million USD | -320.619% |
| Aytu BioPharma, Inc. | 54.58 Million USD | -859.48% |
| Viatris Inc. | 6.43 Billion USD | 91.866% |
| OptiNose, Inc. | 62.35 Million USD | -739.949% |
| SIGA Technologies, Inc. | 122.09 Million USD | -328.973% |
| Tilray Brands, Inc. | 223.35 Million USD | -134.493% |
| PetIQ, Inc. | 252.74 Million USD | -107.226% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -6180.504% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 71.65% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -9608.784% |
| Alimera Sciences, Inc. | 61.17 Million USD | -756.207% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | -60.574% |
| Silver Spike Investment Corp. | 8.1 Million USD | -6363.877% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 7689749.097% |
| Organogenesis Holdings Inc. | 309.79 Million USD | -69.064% |
| Journey Medical Corporation | 52.52 Million USD | -897.205% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -12396.326% |
| Alpha Teknova, Inc. | 10.29 Million USD | -4986.849% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -7888.743% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | -1151.474% |
| PainReform Ltd. | -15 Thousand USD | 3491713.333% |
| Cosmos Health Inc. | 4.34 Million USD | -11941.239% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | -1831.416% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -40125.96% |
| Embecta Corp. | 749.9 Million USD | 30.158% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 70345.498% |
| Talphera, Inc. | -4.89 Million USD | 10799.53% |
| Pacira BioSciences, Inc. | 490.3 Million USD | -6.819% |
| Incannex Healthcare Limited | 12 Thousand USD | -4364416.667% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 21830.446% |
| Shineco, Inc. | 882.16 Thousand USD | -59269.871% |
| Procaps Group, S.A. | 239.56 Million USD | -118.618% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | -71.548% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | -1660.359% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 26.186% |
| Alvotech | -69.42 Million USD | 854.432% |
| Hempacco Co., Inc. | -1.21 Million USD | 43176.804% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | -136.267% |
| Bright Green Corporation | -237.01 Thousand USD | 221073.268% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | -616.797% |
| Kamada Ltd. | 52.59 Million USD | -895.845% |
| Indivior PLC | 907 Million USD | 42.256% |
| Evoke Pharma, Inc. | 4.97 Million USD | -10419.546% |
| Flora Growth Corp. | 17.73 Million USD | -2852.655% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 21830.446% |
| Evolus, Inc. | 140.52 Million USD | -272.701% |
| HUTCHMED (China) Limited | 453.55 Million USD | -15.476% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | -52.265% |
| Akanda Corp. | 111.44 Thousand USD | -469838.716% |